For US Patients
Prescribing Information
IMAAVY® (nipocalimab-aahu)
Log InSign Up For Support

How IMAAVY® (nipocalimab-aahu) works

How does IMAAVY work?

IMAAVY reduces

immunoglobulin G (IgG)
antibodies, including
harmful IgG antibodies
that attach to red blood cells, by binding and blocking neonatal Fc receptor (
FcRn
).

Learn more about wAIHA here

FcRn and your immune system

Diagram of FcRn not being able to distinguish between helpful and harmful IgG antibodies

FcRn is a protein found naturally on some of your cells. Its normal job is to keep IgG antibodies circulating in your bloodstream longer. Under normal circumstances, that is a good thing since most IgG antibodies protect you from germs. But FcRn does not distinguish between helpful and harmful IgG antibodies.

Diagram of harmful IgG antibodies attacking red blood cells

FcRn keeps the harmful IgG antibodies in circulation longer, including the ones that are attacking your red blood cells.

Diagram of IMAAVY blocking FcRn to help reduce the amount of IgG antibodies

IMAAVY is a targeted treatment for wAIHA. By blocking FcRn it helps reduce the amount of IgG antibodies, including harmful IgG antibodies that attack the red blood cells.

Based on research from laboratory and/or clinical studies. The clinical significance of these findings is unknown.

IMAAVY® (nipocalimab-aahu) Transparent Logo leftIMAAVY® (nipocalimab-aahu) Transparent Logo left

Get personalized support tailored
to your unique needs

Once you and your healthcare provider have decided that IMAAVY is right for you, IMAAVY withMe is here for you and your loved ones with free personalized support when and where you may need it.

Sign up for support

Not ready to sign up yet?

Learn more now

IMAAVY® (nipocalimab-aahu) Transparent Logo right
IMAAVY® (nipocalimab-aahu) Transparent Logo right